Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2019 09:00 ET | Source: Tizona Therapeutics Inc

Tizona Therapeutics Appoints Scott Clarke as Chief Executive Officer and Provides Update on Regulatory Milestone for its First-in-Class CD39 program in Cancer

– New Leader to Guide Immunotherapy Biotech in its Next Phase of Growth – – FDA Accepts Tizona’s Investigational New Drug Application for TTX-030 – SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 ...